Complications, haematological cancer — solid tumours | 2020 solid tumours | Control group | HR | 95% CI | p-value |
---|---|---|---|---|---|
n = 201 | n = 168 | ||||
Total catheter days | 29,071 | 37,469 | – | – | – |
CD per patient, median (IQR) | 175 (69) | 217 (179) | – | – | < 0.001 |
Mortality, n (%) | 36 (17.9) | 34 (20.2) | 1.5 | 0.9–2.6 | 0.121 |
DVT, n (%) | 2 (1.0) | 1 (0.6) | 2.0 | 0.2–21.9 | 0.578 |
DVT/1000 CD | 0.07 | 0.03 | – | – | – |
Days to DVT, median (IQR) | 85 (−) | – | – | – | – |
All catheter infections, n (%) | 9 (4.5) | 16 (9.5) | 0.6 | 0.3–1.4 | 0.211 |
Infection/1000 CD | 0.31 | 0.43 | – | – | – |
Local infection, n (%) | 9 (4.5) | 15 (8.9) | – | – | – |
CRI, n (%) | 3 (1.5) | – | – | – | – |
CRBSI, n (%) | 2 (1.0) | 2 (1.2) | 1.8 | 0.2–20.1 | 0.623 |
CRBSI/1000 CD | 0.07 | 0.05 | – | – | – |
Days to infection median (IQR) | 56 (85) | 46 (96) | – | – | 0.428 |
Haematoma, n (%) | 10 (5.0) | 2 (1.2) | – | – | 0.043 |
Antibiotics, n (%) | 22 (10.1) | 2 (1.2) | < 0.001 | ||
Mechanical, n (%) | 6 (3.0) | 7 (4.2) | 1.0 | 0.3–3.0 | 0.945 |
Mechanical/1000 CD | 0.21 | 0.19 | – | – | – |
Days to mechanical event median (IQR) | 16 (57) | 122 (107) | – | – | 0.015 |
Occlusion, n (%) | 18 (9.0) | 1 (0.6) | 16.2 | 2.2–121.1 | 0.007 |
Occlusion/1000 CD | 0.62 | 0.03 | – | ||
Days to occlusion median (IQR) | 17 (43) | – (−) | – | – | – |
All grade adverse events, n (%) | 37 (18.4) | 25 (14.9) | 1.7 | 1.0–2.9 | 0.068 |
All grade adverse events/1000 CD | 1.27 | 0.67 | – | – | – |
Days to all grade adverse events median (IQR) | 22 (63) | 60 (114) | – | – | 0.001 |